Comparing Beta Cell Preservation Across Clinical Trials in Recent-Onset Type 1 Diabetes-Reference-Cited by-同舟云学术

Comparing Beta Cell Preservation Across Clinical Trials in Recent-Onset Type 1 Diabetes

Published:2020-12-01 Issue:12 Volume:22 Page:948-953
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Jacobsen Laura M.¹,Bundy Brian N.²,Greco Madison N.¹,Schatz Desmond A.¹,Atkinson Mark A.³,Brusko Todd M.³,Mathews Clayton E.³,Herold Kevan C.⁴,Gitelman Stephen E.⁵,Krischer Jeffrey P.²,Haller Michael J.¹

Affiliation:

1. Division of Pediatric Endocrinology, University of Florida, Gainesville, Florida, USA.

2. Health Informatics Institute, University of South Florida, Tampa, Florida, USA.

3. Department of Pathology, Immunology, and Laboratory Medicine, University of Florida Diabetes Institute, Gainesville, Florida, USA.

4. Departments of Immunobiology and Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

5. Diabetes Center, University of California San Francisco, San Francisco, California, USA.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2020.0305

Reference15 articles.

1. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

2. Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

3. Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

4. Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial

5. Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune Form des Typ-1-Diabetes mellitus: Mit Kombinationstherapie einer Heilung näher kommen;Deutsches Ärzteblatt Online;2024-06-28

2. Novel Autologous Dendritic Cell Therapy AVT001 for Type 1 Diabetes;NEJM Evidence;2024-06-25

3. Can type 1 diabetes be prevented or reversed?;Journal of Diabetes;2024-05

4. Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials;Diabetes Care;2024-04-15

5. Diabetes Technology and Therapy in the Pediatric Age Group;Diabetes Technology & Therapeutics;2024-03-01